Zacks Research Reduces Earnings Estimates for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY) – Investment analysts at Zacks Research reduced their Q1 2026 earnings estimates for HealthEquity in a note issued to investors on Tuesday, April 15th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.60 per share for the quarter, down from their prior forecast of $0.63. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share. Zacks Research also issued estimates for HealthEquity’s Q2 2026 earnings at $0.69 EPS, FY2026 earnings at $2.86 EPS, Q2 2027 earnings at $0.93 EPS, Q3 2027 earnings at $0.92 EPS, Q4 2027 earnings at $1.02 EPS and FY2027 earnings at $3.63 EPS.

Other equities analysts also recently issued research reports about the company. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reaffirmed an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group decreased their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. KeyCorp dropped their target price on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Wells Fargo & Company increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $111.75.

HealthEquity Stock Up 2.5 %

Shares of HQY opened at $84.52 on Thursday. The company has a market capitalization of $7.31 billion, a P/E ratio of 77.54, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity has a one year low of $65.01 and a one year high of $115.59. The business’s 50 day simple moving average is $95.34 and its 200-day simple moving average is $96.28. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Insiders Place Their Bets

In related news, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director now directly owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,381 shares of company stock worth $1,781,432. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of HQY. Arcadia Investment Management Corp MI acquired a new stake in HealthEquity during the 4th quarter worth approximately $26,000. Versant Capital Management Inc bought a new stake in shares of HealthEquity during the first quarter worth $28,000. Transce3nd LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $29,000. Smartleaf Asset Management LLC lifted its position in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC acquired a new position in HealthEquity in the 4th quarter worth $39,000. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.